Affinity Healthcare Fund, LP 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-03 4:20 pm Purchase |
2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Affinity Healthcare Fund, LP | 299,080 9.230% |
299,080 (New Position) |
Filing |